Dr. S Kumar1, F. Musharraf2, M Jabbar3, T Hussen4, U Ubed5, N Jardaq6, T Alnuaymie7, A Karam8, B Saisayaq9, J Halabja10, BA Chawsh11, BP Shar12, D Rzgar13, AH Koprlu14, A Basheer15, B Ahmed16, S. Nouraldeen Ali17, B Haider18, W Karim19, S. Salahadeen20, Harishankar Sahu21, N Shelar22 1Pharmcology, Associate Vice President, Medical Affairs, Ajanta Pharma* 2Endocrinologist, Malikat Al Rahma Clinic, Erbil ... Read More »
xxx Partners
Tag Archives: Teneligliptin
Real-World Observational Study in Patients on Teneligliptin Therapy for the Management of Type 2 Diabetes Mellitus
1Mehmood Shakir Khudhair (MB ch. B F.I.B.M.S), 2Ali Abdlatef AL- Bayati (Diabetologist), 3Zuhair Ahmed AL- Abody (M.B.Ch.B D.M), 4Sama Atta Gitti (Endocrinologist), 5Haider Ayad Alidrisi (MD), 6Nassar Taha Yaseen (MD), 7Yasameen Riyad Khaleel Alsaffer (Doctorate), 8Haider Mohammad Hassan Alameri (CABM), 9Gelal Altaai (FIBMS), 10Rafid AL- Ameri (MD), 11Amaar Mohammed Saeed Almomin (MD), 12Ibrahim Hani Hussein Al Matoor (MD), 13Ali Hussein ... Read More »
Stability indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Metformin and Teneligliptin in Pharmaceutical Formulation
Ramesh Dhani*, V. Haribaskar, J. Priyanka Department of Pharmaceutical Analysis, Ratnam Institute of Pharmacy, Pidathapolur, Nellore, A.P, India A B S T R A C T A simple, Accurate, precise method was developed for the simultaneous estimation of the Metformin and Teneligliptin in pharmaceutical dosage form. Chromatogram was run through ODS2 C 18 (4.6 x 200mm, 10.0µm)column. Mobile phase containing ... Read More »